Terry Dagnon's Insider Trades & SAST Disclosures
Terry Dagnon's most recent trade in Outlook Therapeutics Inc was a trade of 192,143 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 17, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Terry Dagnon.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 192,143 | 192,143 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 21 Jun 2022 | 10,000 | 1,173,058 (2%) | 0% | 1.1 | 10,500 | Common Stock |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2021 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 06 Dec 2021 | 25,201 | 1,163,058 (2%) | 0% | 1.4 | 34,777 | Common Stock |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.42 per share. | 03 Dec 2021 | 10,000 | 1,137,857 (2%) | 0% | 1.4 | 14,200 | Common Stock |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.09 per share. | 23 Feb 2021 | 15,900 | 1,127,857 (2%) | 0% | 2.1 | 33,199 | Common Stock |
| Outlook Therapeutics Inc | Terry Dagnon | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.55 per share. | 12 Feb 2021 | 63,700 | 1,143,757 (2%) | 0% | 2.6 | 162,435 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges